The global Humanized Mouse Model Market was valued at USD 73.21 million in 2016 and is projected to reach USD 166.24 million by 2025, growing at a CAGR of 9.54% from 2017 to 2025.
A humanized mouse is a genetically modified organism carrying functioning human genes, cells, tissues, and/or organs. Humanized mice are commonly used as Test organisms or models in biological and medical research for human therapeutics.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growing R&D activities involving Humanized Mouse models
1.2 Growing Adoption of Personalized Medicine
1.3 Increasing fund from private and public sector
1.4 Rise in biotechnology and biopharmaceutical researches
2. Market Restraints
2.1 Ethical issues
2.2 Stringent regulations and Govt. Formulations
Market Segmentation:
1. Global Humanized Mouse ModelMarket, by End User:
1.1 Pharmaceutical and Biotechnology Companies
1.2 Contract Research Organizations
1.3 Academic and Research Institutions
2. Global Humanized Mouse ModelMarket, by Type:
2.1 Genetic Humanized Mouse Model
2.2 Cell-Based Humanized Mouse Model
2.2.1 CD34 Humanized Mouse Model (Hu-CD34)
2.2.2 PBMC Humanized Mouse Model
2.2.3 BLT Humanized Mouse Model
3. Global Humanized Mouse Model Market, by Application:
3.1 Oncology
3.2 Immunology and infectious diseases
3.3 Neurosciences
3.4 Toxicology
3.5 Hematopoiesis
3.6 Others
4. Global Humanized Mouse Model Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. The Jackson Laboratory
2. Taconic Biosciences, Inc.
3. Horizon Discovery Group PLC
4. Genoway S.A.
5. Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
6. Humurine Technologies
7. Vitalstar Biotechnology Co., Ltd.
8. Ingenious Targeting Laboratory
9. Axenis S.A.S
10. Trans Genic, Inc.
11. Champions Oncology, Inc.
12. Crown Bioscience, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Humanized Mouse ModelMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL HUMANIZED MOUSE MODELMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HUMANIZED MOUSE MODELMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY END USER
5.1 Pharmaceutical and Biotechnology Companies
5.2 Contract Research Organizations
5.3 Academic and Research Institutions
6 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY TYPE
6.1 Genetic Humanized Mouse Model
6.2 Cell-Based Humanized Mouse Model
6.2.1 CD34 Humanized Mouse Model (Hu-CD34)
6.2.2 PBMC Humanized Mouse Model
6.2.3 BLT Humanized Mouse Model
7 GLOBAL HUMANIZED MOUSE MODEL MARKET, BY APPLICATION
7.1 Oncology
7.2 Immunology and infectious diseases
7.3 Neurosciences
7.4 Toxicology
7.5 Hematopoiesis
7.6 Others
8 GLOBAL HUMANIZED MOUSE MODELMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
9 GLOBAL HUMANIZED MOUSE MODELMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 The Jackson Laboratory
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Taconic Biosciences, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Horizon Discovery Group PLC
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Genoway S.A.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Humurine Technologies
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Vitalstar Biotechnology Co., Ltd.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Ingenious Targeting Laboratory
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Axenis S.A.S
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Trans Genic, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Champions Oncology, Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Crown Bioscience, Inc.
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
11 Appendix
11.1 Related Reports
The Organoid Model Construction Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Animal Model Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
The Primary Care Subscription Model Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Model as a Service (MaaS) Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Medical Vertical Model Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...
The Business Model Innovation Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Business Model Reinvention Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Industry Model Low-Code Development Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Community-Driven Model Service Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Quality Assurance Model for Radiation Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...